chrX-154460195-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_017514.5(PLXNA3):āc.12C>Gā(p.Val4=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 1,201,876 control chromosomes in the GnomAD database, including 20 homozygotes. There are 564 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0089 ( 8 hom., 271 hem., cov: 24)
Exomes š: 0.00096 ( 12 hom. 293 hem. )
Consequence
PLXNA3
NM_017514.5 synonymous
NM_017514.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.406
Genes affected
PLXNA3 (HGNC:9101): (plexin A3) This gene encodes a member of the plexin class of proteins. The encoded protein is a class 3 semaphorin receptor, and may be involved in cytoskeletal remodeling and as well as apoptosis. Studies of a similar gene in zebrafish suggest that it is important for axon pathfinding in the developing nervous system. This gene may be associated with tumor progression. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant X-154460195-C-G is Benign according to our data. Variant chrX-154460195-C-G is described in ClinVar as [Benign]. Clinvar id is 777847.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.406 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00892 (1005/112691) while in subpopulation AFR AF= 0.0302 (938/31086). AF 95% confidence interval is 0.0286. There are 8 homozygotes in gnomad4. There are 271 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLXNA3 | NM_017514.5 | c.12C>G | p.Val4= | synonymous_variant | 2/33 | ENST00000369682.4 | |
PLXNA3 | XM_047442247.1 | c.12C>G | p.Val4= | synonymous_variant | 2/22 | ||
PLXNA3 | XR_007068193.1 | n.187C>G | non_coding_transcript_exon_variant | 2/32 | |||
PLXNA3 | XR_430556.4 | n.187C>G | non_coding_transcript_exon_variant | 2/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLXNA3 | ENST00000369682.4 | c.12C>G | p.Val4= | synonymous_variant | 2/33 | 1 | NM_017514.5 | P1 | |
PLXNA3 | ENST00000495040.1 | n.146-904C>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00890 AC: 1002AN: 112643Hom.: 8 Cov.: 24 AF XY: 0.00773 AC XY: 269AN XY: 34801
GnomAD3 genomes
AF:
AC:
1002
AN:
112643
Hom.:
Cov.:
24
AF XY:
AC XY:
269
AN XY:
34801
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00246 AC: 431AN: 175330Hom.: 4 AF XY: 0.00171 AC XY: 108AN XY: 63240
GnomAD3 exomes
AF:
AC:
431
AN:
175330
Hom.:
AF XY:
AC XY:
108
AN XY:
63240
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000961 AC: 1047AN: 1089185Hom.: 12 Cov.: 30 AF XY: 0.000823 AC XY: 293AN XY: 356133
GnomAD4 exome
AF:
AC:
1047
AN:
1089185
Hom.:
Cov.:
30
AF XY:
AC XY:
293
AN XY:
356133
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00892 AC: 1005AN: 112691Hom.: 8 Cov.: 24 AF XY: 0.00777 AC XY: 271AN XY: 34861
GnomAD4 genome
AF:
AC:
1005
AN:
112691
Hom.:
Cov.:
24
AF XY:
AC XY:
271
AN XY:
34861
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 03, 2018 | - - |
PLXNA3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at